glp-1 obesity drugs news today 2025 A network meta-analysis backed weight-loss benefits with several receptor agonists, with less certainty for newer-generation agents. Read more at the link in bio Pharma Giants Bet on Next-Generation

We tapped obesity medicine physicians for their answer

If your nausea continues or becomes severe, talk your doctor or pharmacist

Pharmaceutical companies have been trying to produce small-molecule GLP-1 agonists that are shelf-stable and can be taken orallyfor instance, Pfizer and Eli Lilly have developed Danuglipron and Orforglipron, respectivelybut we know very little about how they work, said Ali Gler, a neuroscientist at the University of Virginia

But individual responses vary, and regular monitoring confirms your liver is responding well

These effects were not observed in ArcN, PVN, or basolateral amygdala (BLA)